Norepinephrine–dopamine releasing agent
From Wikipedia, the free encyclopedia
Further information: norepinephrine releasing agent and dopamine releasing agent
A norepinephrine–dopamine releasing agent (NDRA) is a type of drug which induces the release of norepinephrine (and epinephrine) and dopamine in the body and/or brain.
Examples of NDRAs include phenethylamine, tyramine, amphetamine, methamphetamine, lisdexamfetamine, cathinone, methcathinone, propylhexedrine, phenmetrazine, pemoline, 4-methylaminorex, and benzylpiperazine.
A closely related type of drug is a norepinephrine–dopamine reuptake inhibitor (NDRI).
See also[]
References[]
External links[]
- Media related to Norepinephrine-dopamine releasing agents at Wikimedia Commons
Human trace amine-associated receptor ligands | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TAAR1 |
| ||||||||||
TAAR2 |
| ||||||||||
TAAR5 |
| ||||||||||
† References for all endogenous human TAAR1 ligands are provided at List of trace amines
‡ References for synthetic TAAR1 agonists can be found at TAAR1 or in the associated compound articles. For TAAR2 and TAAR5 agonists and inverse agonists, see TAAR for references.
|
This pharmacology-related article is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Norepinephrine-dopamine releasing agents
- TAAR1 agonists
- VMAT inhibitors
- Pharmacology stubs
Hidden categories:
- Commons category link is on Wikidata
- All stub articles